Sample sizes are not prohibitive [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2017-07-13 21:54 (3272 d 23:23 ago) – Posting: # 17541
Views: 6,902

Hi to the North!

❝ […] Maybe it's tooooo new after all.


Maybe. Sample sizes are not that bad. The FDA requires tighter release spec’s. Hence, we implemented 0.975 as the default in PowerTOST.

library(PowerTOST)
CVwR <- 0.1 # e.g., Cmax of valproic acid (AUC has ~0.05).
s.r  <- 1   # ratio of swT/swR
CVwT <- mse2CV(CV2mse(CVwR)*s.r)
sampleN.NTIDFDA(CV=c(CVwT, CVwR), details=FALSE)

+++++++++++ FDA method for NTID's +++++++++++
           Sample size estimation
---------------------------------------------
Study design:  2x2x4
log-transformed data (multiplicative model)
1e+05 studies for each step simulated.

alpha  = 0.05, target power = 0.8
CVw(T) = 0.1, CVw(R) = 0.1
True ratio     = 0.975
ABE limits     = 0.8 ... 1.25
Regulatory settings: FDA

Sample size
 n     power
18   0.841790

No problem.

Now swT∕swR 2.

s.r  <- 2
CVwT <- mse2CV(CV2mse(CVwR)*s.r)
sampleN.NTIDFDA(CV=c(CVwT, CVwR), details=FALSE)

+++++++++++ FDA method for NTID's +++++++++++
           Sample size estimation
---------------------------------------------
Study design:  2x2x4
log-transformed data (multiplicative model)
1e+05 studies for each step simulated.

alpha  = 0.05, target power = 0.8
CVw(T) = 0.1417745, CVw(R) = 0.1
True ratio     = 0.975
ABE limits     = 0.8 ... 1.25
Regulatory settings: FDA

Sample size
 n     power
28   0.817760

Still easy.

Boehringer’s formulation change. The family’s slaves planned for T/R 0.85 (tried at lot, couldn’t do better), a CVwR of 80%, and RSABE (old guidance). That’s the infamous 4-period full replicate study in 180 subjects on ClinicalTrials.gov.
Nowadays:

sampleN.NTIDFDA(CV=0.8, theta0=0.85, details=FALSE)

+++++++++++ FDA method for NTID's +++++++++++
           Sample size estimation
---------------------------------------------
Study design:  2x2x4
log-transformed data (multiplicative model)
1e+05 studies for each step simulated.

alpha  = 0.05, target power = 0.8
CVw(T) = 0.8, CVw(R) = 0.8
True ratio     = 0.85
ABE limits     = 0.8 ... 1.25
Regulatory settings: FDA

Sample size

   power
836  0.800870

Oops.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
277 visitors (0 registered, 277 guests [including 17 identified bots]).
Forum time: 21:18 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5